Finanse publiczne · 28/09/2011
FDA Corrects Temporary Regulations on Branded Prescription Drug Fee
The US Food and Drug Administration has issued corrections to temporary regulations regarding the annual fee imposed on pharmaceutical companies that manufacture or import branded prescription drugs, as mandated by the Patient Protection and Affordable Care Act.